NasdaqGS - Nasdaq Real Time Price USD

Novavax, Inc. (NVAX)

7.26

+0.19

+(2.69%)

At close: June 3 at 4:00:01 PM EDT

7.24

-0.02

(-0.26%)

After hours: June 3 at 7:57:19 PM EDT

Novavax to Participate in Upcoming Investor Conferences

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conferences:

PR Newswire 5 days ago

NVAX
+2.69%
Here's Why Novavax (NVAX) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 8 days ago

NVAX
+2.69%
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Zacks 8 days ago

NVAX
+2.69%
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More

BMRN and NVAX are in the spotlight this week following announcement agreement and regulatory update.

Zacks 12 days ago

BMRN

PRME

INZY
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.

Zacks 12 days ago

MRNA

PFE

SNY
BofA Reiterates Hold Rating on Novavax (NVAX) Stock

On May 20, BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10. The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from Sanofi during Q3 and an additional $50 million in the second half of […]

Insider Monkey 13 days ago

NVAX
+2.69%
COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers

The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots. Moderna (MRNA) and Pfizer (PFE) shares move higher on this news, while Novavax (NVAX) takes a dip. D-Wave Quantum (QBTS) sees over 26% of stock gains ahead of Tuesday's market close after unveiling its Advantage 2 quantum computer. Cruiseline operator Viking Holdings (VIK) stock takes a hit today despite the company sharing strong first quarter earnings. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 14 days ago

VIK

QBTS

QBTS-WS
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.

The FDA said Tuesday it will limit future Covid vaccines to older and at-risk Americans. The move buoyed Moderna, BioNTech and Novavax.

Investor's Business Daily 14 days ago

PFE

MRNA

BNTX
Company News for May 20, 2025

Companies In The News Are: NVAX, REGN, RYAAY, ZIM.

Zacks 14 days ago

NVAX
+2.69%

ZIM
The placebo effect: How a new FDA rule could pile more strain onto vaccine developers

The proposed plan would require placebo testing for all new vaccines and could mean additional costs and time for R&D.

Pharma Voice 14 days ago

NVAX
+2.69%
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

On May 19, JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This comes after the Food and Drug Administration (FDA) approved the company’s COVID-19 vaccine, however with limitations. The analyst noted that they view the approval as a solid near-term win for Novavax, Inc. (NASDAQ:NVAX), […]

Insider Monkey 15 days ago

NVAX
+2.69%
Novavax, Shake Shack, solar stocks: Trending Tickers

Market Domination hosts Josh Lipton and Julie Hyman go over some of the day's top trending tickers. Novavax (NVAX) stock is soaring after the company's COVID-19 vaccine was approved by the US Food and Drug Administration (FDA). Shake Shack (SHAK) was downgraded by TD Cowen to Hold from Buy, citing limited multiple expansion. Solar stocks, including First Solar (FSLR), Sunrun (RUN), and Enphase (ENPH), are sinking after Republican lawmakers confirmed that clean-energy tax credits will be ending earlier than planned. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 15 days ago

SHAK

NVAX
+2.69%

RUN
Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine

Novavax Breaks Out as FDA OKs Shot for High-Risk Groups

GuruFocus.com 15 days ago

NVAX
+2.69%

SNY
Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

A downgrade of the U.S. debt rating by Moody's sent U.S. equities lower and Treasury yields higher at midday.

Investopedia 15 days ago

TSLA

XIACY

NVAX
+2.69%
Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers

Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) on the exchange. The US Food and Drug Administration (FDA) approves Novavax's (NVAX) COVID-19 vaccine, sending the pharmaceutical stock surging. Tesla (TSLA) is adding former Chipotle Mexican Grill (CMG) CFO Jack Hartung to its board of directors, effective June 1, when Hartung will be stepping down as the restaurant chain's president and chief strategy officer. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 15 days ago

COIN

DFS

NVAX
+2.69%
Novavax Secures FDA Approval for COVID-19 Vaccine

Novavax (NVAX) on Monday said it received approval from the US Food and Drug Administration for its

PREMIUM
MT Newswires 15 days ago

NVAX
+2.69%

SNY
Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with rival vaccine makers.

Barrons.com 15 days ago

NVAX
+2.69%
NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

The FDA grants full approval to Novavax's protein-based COVID-19 vaccine after nearly a two-month delay, albeit with some new conditions.

Zacks 15 days ago

NVAX
+2.69%

SNY
Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

Investopedia 15 days ago

NVAX
+2.69%

SNY
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

(Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot. The U.S. Food and Drug Administration approved the vaccine, Nuvaxovid, but limited its use to individuals aged 65 and older and people over 12 years who have at least one underlying condition that puts them at high risk due to the illness. The conditions on the label are medically unusual but consistent with the chatter to date, said BTIG analyst Thomas Shrader.

Reuters 15 days ago

NVAX
+2.69%

Performance Overview

Return	NVAX	S&P 500 (^GSPC)
YTD	-9.70%	+1.51%
1-Year	-60.15%	+13.00%
3-Year	-83.78%	+45.32%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Novavax, Inc. (NVAX)

Novavax to Participate in Upcoming Investor Conferences

Here's Why Novavax (NVAX) is a Strong Momentum Stock

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

BofA Reiterates Hold Rating on Novavax (NVAX) Stock

COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers

The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.

Company News for May 20, 2025

The placebo effect: How a new FDA rule could pile more strain onto vaccine developers

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

Novavax, Shake Shack, solar stocks: Trending Tickers

Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers

Novavax Secures FDA Approval for COVID-19 Vaccine

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Performance Overview